← SynDRA
ZIRITAXESTAT
SynDRA canonical compound SYN0038571 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | ENPP2 |
|---|
| Mechanism of action | autotaxin inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- ENPP2 INHIBITOR
- Autotaxin inhibitor
Cross-references
Synonyms
- ZIRITAXESTATN
- GLPG1690
- G-451990
- G451990
- GLPG-1690
- ZIRITAXESTAT (GLPG1690)
- Ziritaxestatn
- I02418V13W
- ziritaxestatum
- RefChem:905363
- MFCD31544330
- Ziritaxestat (GLPG1690)
- Ziritaxestat [USAN]
- GLPG-1690(Ziritaxestat)
- Ziritaxestat [WHO-DD]
- Ziritaxestat (USAN/INN)
- ZIRITAXESTAT [INN]
- GLPG-1690(Ziritaxestat)?
- GTPL9561
- SCHEMBL16051264
- UNII-I02418V13W
- BDBM719985
- GLXC-20278
- EX-A1646
- BDBM50187686
- s8895
- WHO 11017
- AKOS032946267
- CS-7634
- EBC-515462
- SB19736
- compound 11 [PMID: 28414242]
- NCGC00532447-02
- AC-36149
- SY235874
- HY-101772
- US20250051321, Compound GLPG1690
- D11844
Look up ZIRITAXESTAT in the interactive SynDRA portal →